arthropodborn
virus
arbovirus
import
threat
human
anim
health
global
among
zoonot
diseas
account
billion
case
human
ill
million
death
everi
year
repres
increas
public
health
problem
chikungunya
viru
belong
genu
alphaviru
famili
togaririda
transmit
mainli
bite
femal
mosquito
aed
aegypti
andor
albopictu
speci
focu
review
medicin
chemistri
chikungunya
viru
includ
synthet
natur
product
well
ration
design
compound
inhibitor
chikungunya
nonstructur
protein
nsp
evolut
human
speci
infecti
diseas
also
evolv
emerg
new
diseas
resurg
old
one
challeng
human
emerg
infecti
diseas
rapidli
increas
frequenc
geograph
rang
among
zoonot
diseas
account
billion
case
human
ill
million
death
everi
year
constitut
persist
health
problem
worldwid
mosquito
diptera
culidida
vector
pathogen
parasit
health
diseas
dengu
zika
chikungunya
lymphat
filariasi
addit
mosquito
control
great
import
throughout
world
especi
tropic
subtrop
area
howev
use
insecticid
kill
mosquito
led
develop
resist
gener
zoonot
virus
transmit
human
hematophag
insect
mosquito
sandfli
tick
bite
midg
call
arthropodborn
virus
arbovirus
sens
chikungunya
viru
chikv
arthropodborn
viru
belong
genu
alphaviru
famili
togaririda
transmit
bite
femal
mosquito
aed
aegypti
albopictu
furcif
speci
culex
ssp
base
chikv
transmit
urban
cycl
man
mosquito
man
sylvat
cycl
anim
mosquito
man
although
recent
epidem
case
relat
maternalfet
transmiss
chikv
firstli
identifi
epidem
tanzania
global
reemerg
chikv
start
kenya
spread
differ
island
indian
ocean
sinc
end
chikv
infect
report
mani
countri
central
south
american
caus
estim
case
actual
chikv
consid
real
health
problem
aed
mosquito
thrive
unit
state
nation
institut
allergi
infecti
diseas
niaid
includ
chikv
categori
c
prioriti
pathogen
categori
relat
pathogen
could
util
mass
dissemin
futur
due
high
morbid
mortal
rate
major
health
impact
acut
phase
viral
load
reach
viral
particl
per
ml
blood
plasma
concentr
type
interferon
ifn
rang
ng
ml
associ
robust
induct
proinflammatori
cytokin
chemokin
normal
chikv
symptom
begin
day
mosquito
bite
caus
chikungunya
fever
symptom
fever
arthralgia
case
maculopapular
rash
rare
lethal
diseas
proce
infect
patient
chronic
stage
character
persist
sever
polyarthr
predominantli
old
world
virus
occasion
case
eye
heart
gastrointestin
neurolog
complic
report
basic
chikv
ill
sever
joint
pain
ankl
finger
toe
elbow
knee
wrist
addit
patient
fulli
recov
case
joint
pain
may
persist
sever
week
month
year
patient
found
still
antichikv
immunoglobulin
igm
eighteen
month
diseas
onset
gener
chikv
attack
fibroblast
suggest
involv
muscl
joint
skin
connect
tissu
high
number
nerv
end
within
joint
muscl
tissu
explain
pain
associ
chikv
although
physic
exercis
recommend
decreas
joint
stiff
case
chikv
associ
enceph
patient
lead
increasingli
strong
suspicion
chikv
neurotrop
predominantli
new
world
virus
despit
propag
high
morbid
rate
chikv
infect
current
approv
vaccin
antivir
treatment
avail
although
research
recent
report
develop
new
candid
vaccin
protect
chikv
infect
basic
treatment
limit
antipyret
analges
corticosteroid
nonsteroid
antiinflammatori
drug
nsaid
allevi
symptom
addit
diseasemodifi
antirheumat
drug
dmard
methotrex
sulphasalazin
use
sever
case
nsaid
effect
moreov
coinfect
dengu
denv
chikv
zika
zikv
report
patient
although
coinfect
zikv
chikv
appear
increas
sever
diseas
durat
arthriti
final
chronic
inflammatori
rheumat
follow
chikv
infect
rare
potenti
bone
damag
number
case
requir
symptomat
treatment
mainli
nonsteroid
antiinflammatori
drug
physiotherapi
alphavirus
membran
envelop
virus
consist
singlestrand
rna
genet
materi
icosahedrallik
nucleocapsid
size
nm
genet
chikv
possess
envelop
structur
singlestrand
posit
rna
genom
addit
chikv
genom
approxim
kb
long
compris
two
open
read
frame
orf
end
orf
capabl
encod
four
viral
nonstructur
protein
nsp
nsp
end
orf
encod
viral
structur
protein
includ
capsid
c
two
major
envelop
e
glycoprotein
e
e
two
smaller
accessori
peptid
e
envelop
protein
nsp
involv
viral
mrna
cap
via
guanylyltransferas
enzymat
activ
addit
viral
nsp
protein
enzymat
function
includ
rna
helicas
nucleosid
triphosphatas
ntpase
rnadepend
activ
locat
nterminu
protein
proteas
domain
locat
cterminu
nsp
act
part
replicas
unit
accessori
protein
involv
rna
synthesi
final
nsp
act
rnadependentrna
polymeras
envelop
protein
e
e
respons
format
glycoprotein
spike
viral
particl
surfac
facilit
bind
viral
particl
suscept
host
cell
mutat
alanin
valin
e
envelop
glycoprotein
result
new
chikv
strain
becam
preval
epidem
progress
fig
addit
known
alter
arginin
e
protein
respons
observ
chikv
resist
arbidol
drug
also
regul
chikv
adapt
addit
chikv
surfac
consist
trimer
spike
compos
heterodim
envelop
glycoprotein
e
e
lipid
bilay
chikv
small
hydrophob
protein
essenti
viral
particl
assembl
act
signal
sequenc
process
e
protein
role
k
protein
viral
replic
fulli
resolv
capsid
protein
amino
acid
kda
long
express
part
structur
polyprotein
conserv
autoproteas
domain
ctermin
end
help
releas
polypeptid
string
synthesi
structur
protein
sequenc
occur
entri
chikv
viru
via
clathrindepend
endocytosi
uncoat
viral
genom
translat
viral
rna
lead
viral
nonstructur
protein
complex
replic
chikv
rna
genom
step
follow
translat
viral
structur
protein
assembl
viral
compon
within
cytoplasm
final
viral
particl
bud
plasma
membran
form
matur
infecti
progeni
three
genotyp
name
asian
asian
eastern
central
south
african
ecsa
west
african
wa
strain
furthermor
amino
acid
sequenc
ident
chik
alphaviru
rang
case
nonstructur
structur
protein
respect
protein
mediat
key
step
viru
life
cycl
target
design
new
antichikv
drug
inhibit
entri
step
present
attract
therapeut
strategi
damag
caus
virul
factor
intracellular
viral
replic
minim
identif
chikvspecif
receptor
crucial
drive
futur
research
chikv
entri
inhibitor
sever
previou
studi
report
antichikv
activ
compound
approv
drug
vitro
chloroquin
furin
inhibitor
arbidol
mycophenol
acid
picolin
interferona
ribavirin
combin
consid
ifna
ifnb
mainli
produc
leucocyt
fibroblast
associ
chikv
physiopatholog
other
among
chloroquin
test
vivo
prove
poorli
activ
addit
chikv
replic
consid
great
start
point
identifi
potenti
target
develop
novel
antivir
compound
antivir
mechan
agent
valid
basi
antioxid
antiinflammatori
activ
scaveng
capac
immunestimulatori
properti
inhibit
viral
dna
rna
synthesi
inhibit
viral
entri
etc
next
page
studi
organ
properli
describ
chloroquin
fig
antimalari
drug
vitro
antivir
activ
number
virus
includ
hiv
sever
acut
respiratori
syndrom
alphavirus
coronaviru
chloroquin
inhibit
chikv
replic
vero
cell
ic
lm
ic
lm
si
dosedepend
manner
antivir
drug
arbidol
arb
origin
develop
prophylaxi
treatment
acut
respiratori
infect
includ
influenza
recent
shown
arb
exhibit
wide
rang
activ
number
rna
dna
envelop
nonenvelop
virus
fact
suggest
arb
target
common
critic
step
virushost
cell
interact
addit
arb
capabl
block
viru
entri
target
cell
case
influenza
virus
hepat
c
viru
delogu
et
al
investig
cellulo
antivir
arb
metabolit
fig
activ
chikv
differ
cell
line
assay
vero
two
condit
preand
postinfect
treatment
effect
arb
sulfon
sulfoxid
metabolit
chikv
replic
determin
use
specif
indirect
immunofluoresc
observ
inhibit
chikv
infect
ic
valu
lm
addit
cc
valu
obtain
use
vero
lm
lm
cell
line
select
indic
cc
ic
determin
use
vero
cell
line
result
valu
respect
case
arb
metabolit
weak
antivir
activ
observ
ic
valu
lm
concentr
vero
cell
line
final
order
investig
direct
inactiv
effect
ic
valu
obtain
lm
min
incub
lm
min
incub
indic
antivir
activ
chikv
infect
due
virucid
activ
di
mola
et
al
use
design
novel
analog
antichikv
activ
aim
improv
therapeut
index
identifi
novel
lead
compound
tabl
summar
result
inhibitori
activ
determin
compound
respect
ethyl
seri
compound
note
substitu
introduc
para
posit
thiophenol
ring
loss
antichikv
activ
observ
except
compound
ec
lm
introduct
two
bulki
chlorin
atom
posit
led
select
inhibit
substitut
ethyl
ester
posit
tertbutyl
ester
result
compound
activ
ec
valu
rang
lm
best
compound
potent
seri
ec
lm
also
less
cytotox
select
index
higher
final
obvious
note
presenc
electronwithdraw
group
para
posit
thiophenol
ring
lead
molecul
antivir
activ
deriv
present
opposit
activ
suggest
posit
steric
hindranc
halogen
influenc
antivir
activ
therefor
deriv
lowest
ec
valu
convert
correspond
sulfoxid
deriv
oxid
compound
sulfoxid
led
decreas
antichikv
activ
cytotox
replac
trifluoromethyl
group
para
ortho
posit
result
increas
potenc
reduc
cytotox
addit
similar
effect
observ
simultan
presenc
two
chlorin
atom
ortho
posit
effect
oxid
two
compound
belong
ethyl
seri
also
evalu
compound
increas
activ
observ
without
reduct
cytotox
addit
introduct
two
chlorin
atom
ortho
posit
respons
decreas
activ
fact
compound
present
higher
ec
valu
smaller
select
index
unsubstitut
analog
subsequ
evidenc
carboxyl
acid
deriv
interest
tertbutyl
ester
complet
inact
final
demonstr
compound
hydroxymethyl
group
posit
replac
ethyl
ester
complet
inact
except
present
moder
activ
howev
low
select
index
base
result
obtain
di
mola
et
al
new
arbidol
analog
propos
scuotto
et
al
studi
three
new
seri
compound
synthes
evalu
chikv
vero
cell
use
cpe
assay
tabl
addit
e
unit
crystal
structur
matur
e
e
e
glycoprotein
complex
pdb
id
use
simul
correspond
crystal
structur
two
potenti
bind
site
proxim
identifi
compound
ethyl
present
high
activ
ic
lm
select
index
si
addit
bgm
cell
assay
use
chikv
pseudoparticl
chikvpp
demonstr
molecular
mechan
action
occur
entri
postentri
viral
particl
probabl
also
associ
mechan
closest
site
site
indic
small
hydrophil
shallow
pocket
probabl
bind
site
site
consist
hydrophob
welldefin
pocket
form
directli
involv
site
format
note
residu
locat
flexibl
loop
specul
substitut
arginin
significantli
bigger
residu
could
chang
loop
conform
affect
overal
architectur
propos
site
way
occupi
bind
site
insert
ethyl
ester
group
thiophenol
deep
pocket
wherea
dimethylamino
moieti
hydroxyl
group
solvent
expos
jadav
et
al
perform
investig
antichikv
activ
benzyliden
rhodanin
thiazolidin
deriv
tabl
compound
assum
activ
chikv
addit
compound
contain
orthomethyl
group
found
potent
compound
compound
tabl
novel
arbidol
deriv
antichikv
activ
vero
cell
group
inhibit
chikv
concentr
similar
compound
follow
compound
contain
paramethyl
group
observ
arylkyliden
portion
nonpolar
natur
exert
activ
fact
support
inact
compound
polar
group
paraposit
compound
heteroaryl
ring
lg
ml
concentr
addit
compound
found
activ
compound
orthonitro
substitut
compound
metamethyl
substitut
present
activ
lg
ml
concentr
appli
novel
viru
entri
assay
identif
alphaviru
entri
inhibitor
pohjala
et
al
found
six
compound
moieti
includ
chlorpromazin
ethopropazin
methdilazin
perphenazin
thiethylperazin
thioridazin
found
possibl
entri
inhibitor
tabl
although
molecular
mechan
compound
inhibit
viral
entri
yet
remain
obscur
epigallocatechin
gallat
egcg
fig
repres
major
constitu
green
tea
extract
known
egcg
tabl
antivir
activ
rhodanin
thiazolidin
deriv
chikv
nd
show
activ
lg
ml
perform
studi
antichikv
capac
extract
compound
leav
tectona
grandi
lin
commonli
known
teak
folklor
medicin
studi
three
compound
isol
character
butoxycarbonyl
benzoic
acid
compound
evalu
activ
two
strain
chikv
asian
african
chikungunya
virus
perform
use
ribavirin
posit
control
tabl
antivir
activ
compound
compar
refer
drug
ribavirin
mtt
assay
addit
select
indic
compound
asian
strain
african
strain
final
compound
found
highli
signific
therapeut
index
asian
strain
african
strain
tannin
capabl
inhibit
vitro
infect
anim
virus
herp
influenza
other
addit
tannin
abl
reduc
permeabl
erythrocyt
anion
nonelectrophil
inhibit
enzym
action
agglutin
erythrocyt
base
konishi
hotta
perform
studi
examin
mechan
virusinactiv
action
tannin
deal
interact
chikv
african
strain
tannic
acid
relat
compound
fig
cell
compound
ppm
concentr
less
ph
present
cytotox
effect
cell
morpholog
chang
subsequ
assay
carri
use
ppm
concentr
ph
observ
effect
viru
invad
cell
condit
ppm
capabl
reduc
chikv
infect
result
confirm
suppress
use
bovin
serum
albumin
bsa
wide
known
present
bind
action
tannin
protein
addit
almost
effect
effect
well
significantli
weaker
deriv
present
littl
effect
final
result
report
indic
inactiv
chikv
vitro
although
may
also
affect
cultur
cell
inactiv
show
close
relat
phenol
hydroxyl
group
sinc
displac
hydroxyl
group
methoxyl
make
chemic
ineffect
ie
reduct
group
lead
effect
weaker
ie
ineffect
may
possibl
suggest
exist
carboxyl
group
indirectli
relat
action
hydroxyl
group
comparison
carboxyl
group
seem
directli
activ
ie
studi
perform
kaur
et
al
verifi
harringtonin
act
postentri
stage
chikv
replic
cycl
strongli
interfer
process
viral
protein
synthesi
harringtonin
fig
extract
japanes
plum
yew
cephalotaxu
harringtonia
belong
cephalotaxin
ester
class
inhibit
chikv
replic
observ
lm
harringtonin
ad
late
time
point
timeofaddit
studi
may
suggest
addit
mechan
inhibit
high
concentr
harringtonin
affect
later
phase
chikv
replic
cycl
mockinfect
cell
wang
et
al
shown
chikv
mediat
insect
cell
fusion
assay
could
use
search
antichikv
drug
platform
suggest
antialphavirus
properti
niclosamid
nitazoxanid
also
affect
chikv
entri
transmiss
verifi
potenti
use
human
cell
prove
cell
tabl
also
found
signific
inhibit
celltocel
transmiss
chikv
infect
consid
import
transmiss
pathway
allow
virus
avoid
attack
immun
system
niclosamid
nitazoxanid
promis
compound
develop
antichikv
drug
inhibitor
chikungunya
nonstructur
protein
nsp
quinin
fig
antimalari
drug
abl
inhibit
chikv
vitro
ic
valu
lg
ml
final
suggest
compound
capabl
affect
nsp
mutat
protein
occur
upon
grow
viru
high
concentr
singh
et
al
develop
homolog
model
nsp
screen
librari
compound
silico
lead
four
compound
promis
inhibitor
nsp
proteas
fig
similarli
bassetto
et
al
perform
silico
studi
identifi
chikv
nsp
inhibitor
use
virtual
screen
protocol
larg
compound
librari
employ
develop
homolog
model
chikv
nsp
proteas
among
compound
hit
compound
found
bind
central
portion
nsp
proteas
activ
site
fig
vitro
activ
compound
show
inhibit
viru
ec
lm
select
index
si
inhibit
virusinduc
cytopath
effect
cpe
final
novel
analog
fig
propos
base
compound
structur
antivir
activ
slightli
improv
display
ec
lm
si
moreov
bind
pose
compound
found
similar
analog
activ
site
nsp
hydrazon
group
place
region
defin
catalyt
dyad
also
close
cyclopropan
moieti
posit
space
formerli
occupi
second
glycin
residu
nsp
link
peptid
relev
interact
observ
hydrophob
contact
ring
side
chain
two
hydrogen
bond
bond
hydrazon
function
amid
group
skeleton
anoth
interact
hydrophob
group
tbutyl
group
addit
substitut
hydrazon
group
would
benefici
overcom
possibl
problem
chemic
instabl
suscept
hydrolysi
way
compound
cyclopropyl
group
replac
transethenyl
function
allow
maintain
length
geometri
origin
ligand
avoid
presenc
chiral
center
molecul
simplifi
structur
compound
allow
rapid
effici
optim
class
treatment
use
access
synthet
rout
way
action
novel
inhibitor
relat
promis
repres
initi
step
toward
find
clinic
candid
treatment
chikv
infect
sangeetha
et
al
perform
silico
studi
use
crystal
structur
chikv
protein
nsp
proteas
pdb
id
nonstructur
pdb
id
obtain
protein
data
bank
envelop
capsid
nonstructur
predict
silico
model
use
blast
onlin
platform
final
result
show
compound
interact
protein
val
fig
lowaffin
energi
kcal
mol
jadav
et
al
employ
molecular
dock
simul
order
understand
possibl
mechan
action
best
rhodanin
deriv
see
tabl
chikv
nsp
proteas
pdb
id
dock
analys
interact
observ
summar
tabl
base
result
obtain
dock
analysi
conclud
hydrophob
interact
pocket
hbond
distanc
interact
critic
activ
potenc
compound
fig
inhibitor
chikungunya
nonstructur
protein
nsp
comparison
chikv
protein
function
alphaviru
replicas
protein
nsp
still
uncertain
present
discov
inhibitor
protein
flavonoid
plant
polyphenol
compound
possess
wide
rang
biolog
properti
human
health
antioxid
antiinflammatori
antibacteri
antifung
activ
actual
known
variou
type
flavonoid
rutin
naringin
baicalein
quercetin
kaempferol
potenti
antivir
agent
dengu
viru
influenza
virus
hiv
coxsacki
viru
japanes
enceph
viru
sens
consid
molecular
dock
acceler
drug
design
process
broadli
use
biopharmaceut
industri
discov
develop
new
lead
compound
seyedi
et
al
perform
studi
predict
valid
pose
receptor
conform
nsp
pdb
id
set
contain
four
ligand
adpribos
baicalin
naringenin
quercetagetin
use
score
base
bind
affin
ligand
conform
rank
accord
predict
bind
affin
use
default
score
function
autodock
vina
best
dock
conform
show
bind
affin
kcal
mol
wherea
among
three
ligand
analyz
present
potent
antivir
activ
bind
affin
kcal
mol
tabl
addit
evidenc
flavonoid
capabl
interact
residu
activ
site
final
also
observ
one
pp
stack
interact
residu
respect
flavonoid
show
hbond
distanc
rang
review
szatylowicz
classifi
energi
border
set
strong
moder
weak
hbond
consid
involv
chikv
intracellular
replic
cycl
result
suggest
could
potenti
interfer
postentri
stage
chikv
infect
advanc
highthroughput
approach
shown
altern
pathway
effici
identifi
novel
molecul
util
design
new
strategi
combat
spread
viru
possibl
bind
target
site
chikv
envelop
protein
previous
investig
sens
rashad
keller
investig
first
time
identif
possibl
antagonist
e
e
site
virtual
screen
use
two
success
dock
score
fred
dock
fast
precis
screen
use
top
hit
subject
rank
score
use
autodock
algorithm
addit
immatur
pdb
id
matur
pdb
id
e
e
protein
complex
structur
chikv
includ
studi
increas
probabl
find
posit
reliabl
hit
final
sever
molecul
identifi
good
silico
chikungunya
viru
envelop
protein
inhibitor
tabl
initi
two
chemic
compound
librari
use
nci
compound
life
chemic
proteinprotein
interact
inhibitor
librari
compound
addit
filter
appli
molecular
weight
clogp
hydrogen
bond
donor
hbd
acceptor
hba
oh
nh
n
subsequ
molecular
dock
calcul
perform
use
previous
select
compound
fred
program
dock
analys
pose
retriev
score
rank
gaussian
shape
function
independ
five
avail
score
function
plp
chemscor
oechemscor
screenscor
total
seven
site
detect
e
e
protein
complex
site
show
interest
studi
site
repres
surfac
activ
lie
e
domain
ii
e
bribbon
connect
e
domain
e
domain
c
addit
make
close
contact
residu
e
e
protein
e
residu
e
residu
correspond
matur
form
matur
form
gener
valin
alanin
prolin
amino
acid
within
pocket
also
abl
particip
hydrophob
interact
site
presenc
electron
rich
system
lead
strong
noncoval
molecular
interact
addit
heterocycl
ring
adjac
sulfur
toprank
pose
accept
hydrogen
bond
e
site
describ
narrow
channel
extend
behind
fusion
loop
surround
e
domain
fusion
loop
found
critic
fusion
e
residu
matur
form
matur
form
form
close
contact
activ
site
moreov
predict
bind
affin
inhibitori
constant
ki
nm
rang
along
clogp
valu
make
compound
site
matur
immatur
protein
attract
candid
develop
antichikv
drug
target
envelop
protein
inhibitor
viral
genom
replic
ribavirin
ribavirin
synthet
guanosin
analog
broadspectrum
antivir
activ
compound
show
exert
vitro
antichikv
ec
lm
result
synergist
effect
combin
ifna
addit
combin
doxycyclin
fig
led
good
antivir
effect
chikv
replic
vero
cell
also
reduc
viral
load
inflammatori
process
infect
mice
mycophenol
acid
map
fig
broadli
use
immunosuppress
prevent
reject
transplant
transplant
organ
sens
khan
et
al
report
effect
compound
inhibit
chikv
ic
lm
cc
lm
si
replic
vero
cell
fig
uridin
deriv
broadspectrum
antivir
activ
dna
rna
virus
capabl
inhibit
vitro
chikv
replic
ec
lm
vero
cell
basic
deplet
intracellular
utppool
justifi
activ
quickli
replic
viru
chikv
favipiravir
broadspectrum
antivir
agent
recent
approv
japan
treatment
influenza
viru
infect
base
delang
et
al
report
analog
inhibit
replic
differ
laboratori
strain
clinic
isol
chikv
vero
cell
tabl
studi
perform
ching
et
al
literatur
review
known
inhibitor
relat
arbovirus
examin
start
synthes
small
librari
differ
class
compound
name
pyrazolin
thieno
pyrrol
pyrimidinonespyrimidinethion
report
inhibitor
flaviviru
alphavirus
base
screen
studi
thieno
pyrrol
famili
present
promis
antichikv
activ
use
prepar
differ
activ
analog
tabl
initi
primari
screen
antichikv
activ
measur
use
gaussia
luciferasebas
gene
assay
chikvgluc
compound
show
best
select
index
si
addit
direct
relationship
observ
electroneg
substitu
antivir
activ
cytotox
final
also
observ
thieno
pyrrol
similar
substitu
show
poorer
activ
compar
correspond
amid
subsequ
potent
compound
chikvgluc
screen
select
studi
involv
antivir
activ
wildtyp
chikv
valu
mean
sd
independ
experi
b
c
ec
valu
chikvgluc
determin
inhibit
gaussia
luciferas
express
antivir
assay
ec
valu
wildtyp
wt
chikvimt
calcul
effect
concentr
compound
requir
inhibit
chikvimt
infect
cell
viabil
cc
valu
determin
celltiterglo
luminesc
assay
h
exposur
hek
cell
defin
compound
concentr
requir
reduct
cell
viabil
compar
untreat
control
e
select
index
abamectin
berberin
bromocriptin
fenretinid
ivermectin
order
identifi
activ
compound
chikv
replic
varghes
et
al
investig
approxim
compound
includ
approv
drug
substanc
clinic
trial
viral
replic
evalu
use
renilla
reniformi
luciferas
rluc
reveal
five
hit
compound
abamectin
ivermectin
berberin
show
high
inhibit
activ
chikv
bromocriptin
fenretinid
inhibit
respect
addit
toxic
inhibitori
concentr
evalu
upon
two
differ
cell
line
babi
hamster
kidney
human
hepatocellular
tabl
observ
tabl
compound
macrocycl
lacton
produc
ferment
streptomyc
avemitili
fungu
compound
abl
inhibit
rna
synthesi
viral
protein
express
downregul
nsp
nsp
cell
addit
also
abl
inhibit
rna
synthesi
condit
although
capabl
interf
viral
protein
express
observ
final
abl
inhibit
chikv
dosedepend
respons
furthermor
compound
demonstr
found
promis
antivir
agent
other
alphavirus
semliki
forest
sindbi
virus
flavonoid
natur
compound
structur
apigenin
chrysin
silybin
fig
report
inhibit
replic
rhinovirus
picornavirus
chikv
hiv
shown
flavonoid
inhibit
chikv
replic
ic
valu
rang
mm
gain
entri
host
cell
ineffect
prevent
entri
viru
host
cell
addit
studi
ethanol
extract
cynodon
dactylon
provid
prepar
fraction
rich
luteolin
fig
flavonoid
exhibit
potenti
antichikv
activ
effect
use
reduc
inflamm
joint
therebi
reduc
sever
diseas
studi
extract
huangchin
plant
scutellaria
baicalensi
scutellaria
lateriflora
demonstr
inhibit
differ
stage
denv
replic
vitro
flavonol
fisetin
quercetagetin
fig
shown
variant
base
posit
substitu
attach
basic
structur
flavan
nucleu
pyran
compound
shown
signific
vitro
antivir
activ
replic
dengu
viru
enteroviru
compound
potenti
antivir
activ
hcmv
hepat
c
viru
base
result
investig
toward
antichikv
perform
compound
exhibit
stronger
antivir
activ
chikv
intracellular
replic
ic
si
valu
respect
compound
show
signific
effect
chikv
bind
vero
cell
ic
mm
si
identifi
roughli
mechan
action
compound
intracellular
replic
compound
interfer
stage
convert
negativestrand
rna
positivestrand
rna
data
western
blot
analys
suggest
antivir
function
began
inhibit
translat
nonstructur
protein
lead
decreas
product
level
replicas
unit
anthraquinon
deriv
chikv
test
base
proteas
inhibitor
found
denv
identifi
plausibl
drug
target
involv
viral
replic
mammalian
host
cell
show
inabl
penetr
cell
membran
lack
cellular
antivir
activ
except
anthraquinon
compound
fig
potent
inhibitor
reduc
dengu
viral
titer
log
pfuml
lm
assay
involv
cell
line
highli
permeabl
membran
without
cytotox
human
hepatocarcinoma
cell
infect
chikv
shown
minim
inhibit
infect
mm
approxim
reduct
logunit
pfuml
way
anthraquinon
could
serv
basi
studi
medicin
chemistri
chikv
lanatosid
c
recent
report
lanatosid
c
fig
inhibit
variou
negativestrand
rna
virus
food
drug
recent
discov
bryostatin
analog
incorpor
differ
aor
bring
function
salicyl
group
place
ab
ring
system
protect
cell
chikvinduc
cell
death
ec
valu
low
lm
rang
tabl
relat
salicylatebas
analog
compound
develop
inhibit
chikv
replic
novel
yet
still
elus
nonpkc
depend
pathway
studi
ongo
unravel
precis
molecular
mechan
bryostatin
analog
inhibit
chikv
replic
hosttarget
antivir
furin
inhibitor
besid
chloroquin
infect
alphavirus
inhibit
vitro
block
intracellular
cleavag
viral
envelop
glycoprotein
alphaviru
envelop
glycoprotein
initi
produc
precursor
e
e
viral
matur
cleav
short
multibas
motif
among
cellular
proteas
basic
amino
acidspecif
furin
furinlik
proprotein
convertas
pc
consid
involv
ca
process
result
cleavag
surfac
glycoprotein
ctermin
consensu
sequenc
kr
x
kr
r
studi
perform
ozden
et
al
shown
among
larg
panel
pc
furin
also
furinlik
proteas
could
process
chikv
e
e
vitro
vivo
addit
investig
inhibitori
effect
irrevers
furin
peptid
decanoylargvallysargchloromethyl
keton
decrvkrcmk
fig
chikv
infect
human
muscl
satellit
cell
interestingli
observ
strong
inhibit
chikv
entri
pretreat
cell
convertas
inhibitor
decrvkrcmk
consequ
pretreat
muscl
cell
decrvkrcmk
affect
viru
entri
number
infect
foci
protein
kinas
c
pkc
famili
relat
serinethreonin
kinas
regul
sever
cellular
process
prolifer
differenti
apoptosi
phosphoryl
pathway
signal
accord
abdelnabi
et
al
prostratin
phorbol
ester
origin
isol
croton
oil
croton
tiglium
report
inhibit
entri
hiv
compromis
latent
hiv
viral
reservoir
addit
shown
inhibit
replic
chikv
vitro
howev
mechan
remain
poorli
elucid
tabl
summar
result
antichikv
activ
upon
chikv
indian
ocean
strain
chikv
isol
singapor
reunion
island
caribbean
compound
inhibit
chikv
rna
synthesi
product
infecti
viru
progeni
addit
reduc
accumul
viral
protein
capsid
dosedepend
manner
data
strongli
indic
prostratin
cellprotect
effect
direct
inhibitori
effect
chikv
replic
pkc
inhibit
base
result
antivir
effect
differ
pkc
inhibitor
rottlerin
known
mallotoxin
sotrastaurin
determin
buffalo
green
monkey
kidney
cell
bgm
cpe
reduct
assay
none
test
pkc
inhibitor
inhibit
chikv
replic
highest
nontox
concentr
tabl
bourjot
et
al
perform
chemic
studi
vietnames
plant
speci
trigonostemon
howii
led
isol
new
tiglianetyp
diterpenoid
trigowiin
along
sever
know
coumarin
phenylpropanoid
addit
studi
includ
four
structur
close
relat
tiglian
diterpen
phorbol
tpa
antichikv
assay
employ
posit
control
result
shown
tabl
chikv
assay
observ
prove
potent
inhibitor
appar
lower
potent
ec
valu
higher
select
indic
comparison
refer
compound
shown
addit
prove
averag
time
potent
time
potent
found
complet
inact
final
take
account
antivir
assay
probabl
mechan
suggest
author
mechan
could
associ
activ
signal
transduct
enzym
pkc
similar
mechan
inhibit
hiv
replic
perform
polycytidyl
acid
poli
c
fig
synthet
doublestrand
rna
dsrna
analog
addit
immunostimul
act
induc
potent
interferon
inf
via
interact
tolllik
receptor
moreov
activ
lead
innat
immun
respons
mani
differ
type
virus
accord
li
et
al
chikv
found
sensit
innat
immun
respons
induc
final
sensit
assum
relat
decreas
cytopath
effect
inhibit
viru
replic
infect
cell
line
furthermor
step
involv
overstimul
well
antivir
gene
studi
perform
allard
et
al
trigocherrin
ad
trigocherriolid
ad
compound
possess
daphnan
diterpenoid
skeleton
isol
trigonostemon
cherrier
euphorbiacea
present
select
inhibitor
chikv
replic
result
group
tabl
known
azathioprin
fig
respons
chang
resist
intact
host
viral
infect
base
geme
et
al
perform
potenti
inhibitor
chikv
strain
observ
titer
interferon
cultur
treat
uniformli
less
control
cultur
rang
unit
ml
final
consid
fail
inhibit
synthesi
action
interferon
differ
aspect
host
resist
viral
infect
consid
delay
hypersensit
may
consid
techer
et
al
develop
bioassay
guid
fraction
ethyl
acet
bark
extract
stillingia
lineata
ssp
lineata
viruscellbas
assay
chikv
vero
cell
well
character
diterpen
use
mhz
cosi
noesi
hsqc
hmbc
mass
spectrometri
lineata
ssp
lineata
ethyl
acet
bark
extract
select
due
potent
antichikv
activ
ec
lg
ml
weak
cytotox
vero
cell
cc
lg
ml
addit
use
prepar
semiprepar
hplc
allow
purifi
three
rare
macrocycl
diterpen
tonantzitlolon
tonantzilolon
hydroxytonantzitolon
one
pimaran
fig
accord
techer
et
al
select
inhibit
virusinduc
cell
death
ec
select
index
si
valu
lm
respect
addit
select
ec
lm
si
comparison
two
structur
perform
observ
presenc
acetyl
group
import
improv
activ
employ
joint
screen
program
identifi
novel
compound
chikv
select
antivir
activ
structur
divers
collect
chemic
compound
csic
madri
found
select
viruscellbas
assay
chikv
replic
ku
leuven
one
chemic
sampl
code
portray
interest
activitycytotox
appli
highperform
liquid
chromatographymass
spectrometri
hplsm
analysi
found
hit
sampl
mixtur
two
compound
subsequ
entiti
separ
use
chromatographi
structur
character
individu
evalu
antichikv
activ
last
reveal
chlorocompound
inact
deriv
present
antivir
activ
ec
valu
lm
base
result
compound
select
prepar
structur
analog
explor
structureact
relat
ship
compound
class
detail
total
compound
synthes
evalu
antichikv
activ
upon
vero
cell
tabl
respect
first
seri
compound
reveal
carbonyl
group
requir
posit
heterocycl
base
exhibit
antivir
activ
compound
addit
compound
nh
nhme
ome
group
posit
compound
respect
significantli
less
activ
complet
inact
also
nh
group
posit
show
unsubstitut
base
lack
activ
nme
deriv
addit
triazolopyrimidin
compound
replac
analog
imidazopyrimidin
antivir
activ
could
observ
ec
valu
higher
compound
also
methyl
group
introduc
posit
purin
antivir
activ
lost
regard
substitu
aryl
ring
compound
molecular
featur
antivir
activ
also
quit
strict
compound
ome
chloro
benzoyl
isopropoxi
group
posit
associ
acetyl
hit
compound
produc
best
antivir
activ
addit
ome
group
introduc
posit
ec
higher
ome
group
posit
comparison
furthermor
move
acetyl
group
posit
posit
compound
comparison
led
decreas
antivir
profil
best
ec
valu
observ
substitu
isopropoxi
compound
acetyl
posit
aryl
ring
hydrogen
posit
base
inact
suggest
import
posit
heterocycl
antivir
activ
fact
better
observ
evalu
compound
compound
present
antivir
activ
although
mani
case
fact
accompani
addit
cytotox
accord
cc
valu
interestingli
compound
contain
ethyl
group
posit
present
interest
ec
ec
valu
cytotox
lm
sens
compound
select
index
si
potent
select
compound
among
triazolopyrimidin
better
profil
control
compound
chloroquin
final
benzyl
deriv
least
less
potent
aryl
analog
hit
compound
potent
compound
seri
evalu
select
antivir
assay
differ
chikv
strain
tabl
compound
time
activ
hit
compound
ec
valu
low
micromolar
rang
best
valu
lm
chikv
cong
strain
compound
significantli
activ
factor
african
congo
strain
strain
addit
antivir
activ
found
compound
hwu
et
al
synthes
new
uracilcoumarinaren
conjug
evalu
antivir
activ
chikv
replic
upon
vero
cell
tabl
among
five
conjug
show
signific
inhibit
vitro
chikv
replic
low
toxic
addit
structureact
relationship
studi
reveal
compound
benzouracilsch
coumarinoso
aren
scaffold
potent
inhibitor
seri
bourjot
et
al
perform
investig
antichikv
potenti
triterpenoid
metabolit
isol
lupenon
bamyron
fig
anacolosa
pervilleana
name
madagascan
plant
viruscel
base
assay
chikv
observ
compound
show
moder
antichikv
activ
ic
valu
lm
respect
purinebas
inhibitor
hoogh
et
al
report
design
synthesi
novel
seri
purineblactam
hybrid
purineaminopropanol
hybrid
potenti
antivir
activ
total
nine
differ
virus
includ
studi
result
show
two
purineblactam
hybrid
one
purineaminopropanol
hybrid
fig
present
promis
activ
cytotox
profil
purineblactam
ec
valu
lm
si
purineblactam
ec
valu
lm
si
purineaminopropanol
ec
lm
si
final
mechan
action
investig
data
mean
valu
standard
deviat
least
three
independ
experi
b
effect
concentr
calcul
concentr
compound
requir
protect
cell
cytopath
effect
caus
viral
infect
c
effect
concentr
calcul
concentr
compound
requir
protect
cell
cytopath
effect
caus
viral
infect
cytotox
concentr
calcul
concentr
compound
reduc
overal
cell
metabol
activ
combin
cytotox
cytostat
antimetabol
effect
larvicid
ovicid
oviposit
deterr
agent
hedychium
larsenii
essenti
oil
alshebl
et
al
report
larvicid
oviposit
deterr
activ
hedychium
larsenii
essenti
oil
aegypti
vector
addit
two
major
constitu
essenti
oil
isol
arcurcumen
epibbisabolol
essenti
oil
extract
leav
h
larsenii
present
moder
larvicid
activ
tabl
addit
show
lc
lg
ml
lg
ml
tabl
final
oviposit
deterr
activ
h
larsenii
essenti
oil
evalu
result
shown
tabl
bandyopadhyay
et
al
perform
synthesi
arylhydrazon
ester
scheme
initi
found
better
attract
result
case
unsymmetr
arylhydrazon
ester
symmetr
structur
oviposit
respons
studi
albopictu
perform
accord
method
describ
linley
oviposit
activ
assum
oviposit
activ
index
oai
compound
oai
superior
consid
attract
inferior
consid
repel
tabl
among
compound
show
great
posit
oviposit
stimul
oai
valu
albopictu
addit
observ
phenyl
ring
replac
naphthalen
ring
oviposit
attract
activ
increas
oai
term
present
highest
oviposit
deterr
activ
oai
valu
final
oviposit
respons
found
neutral
compound
actual
therapeut
altern
involv
antivir
drug
natur
product
metabolit
immunomodulatori
strategi
need
better
evalu
subgroup
chronic
patient
howev
altern
expect
improv
evidencebas
scientif
clinic
studi
despit
sever
studi
involv
biolog
target
biomolecular
approach
physiopatholog
mechan
remain
poorli
understood
addit
major
problem
lack
anim
model
perfectli
reproduc
human
chronic
stage
chikungunya
diseas
final
chikungunya
viru
repres
seriou
public
health
problem
world
longer
ignor
sens
urgent
need
develop
safe
effect
antivir
chikv
control
symptom
minim
complic
futur
epidem
well
combat
vector
differ
stage
life
cycl
tabl
oviposit
deterr
activ
hedychium
larsenii
essenti
oil
arcurcumen
epibbisabolol
denguechikungunya
vector
aed
aegypti
